Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Pharmacogenetics of major depressive disorder: top genes and pathways toward clinical applications.

Current psychiatry reports - 1 Jul 2015

Fabbri Chiara, Serretti Alessandro

Abstract excerpt

The pharmacogenetics of antidepressants has been not only a challenging but also frustrating research field since its birth in the 1990s. Indeed, great expectations followed the first evidence of familiar aggregation of antidepressant response. Despite the progress from candidate gene studies to...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antidepressive Agents
Share to ATP Binding Cassette Transporter, Subfamily B
Share to Cytochrome P-450 Enzyme System

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Depressive Disorder, Major

Share to Genome-Wide Association Study

Share to Neuronal Plasticity

Share to Pharmacogenetics

Share to Serotonin Plasma Membrane Transport Proteins

Source

Identifiers

PMID: 25980509
DOI: 10.1007/s11920-015-0594-9

Genes

ABCB1
BDNF
FKBP5
GNB3

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-25980509-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Pharmacogenetics of major depressive disorder: top genes and pathways toward clinical applications.PMID 25980509Read ↗

Progress and prospects in pharmacogenetics of antidepressant drugsSemantic proximity Read ↗

Genetics of Treatment Outcomes in Major Depressive Disorder: Present and FutureSemantic proximity Read ↗

Pharmacogenetic studies: a tool to improve antidepressant therapy.Semantic proximity Read ↗

Consensus paper of the WFSBP Task Force on Genetics: Genetics, epigenetics and gene expression markers of major depressive disorder and antidepressant responseSemantic proximity Read ↗

Genetics and major depressive disorder: clinical implications for disease risk, prognosis and treatment.Semantic proximity Read ↗

Antidepressant pharmacogeneticsSemantic proximity Read ↗

From Pharmacogenetics to Pharmacogenomics: The Way toward the Personalization of Antidepressant TreatmentSemantic proximity Read ↗

The role of pharmacogenetics in the treatment of depression and anxiety disorders.Semantic proximity Read ↗

From pharmacokinetic genes to polygenic scores and multi-omic integration: advances toward precision psychiatry.Semantic proximity Read ↗

Pharmacogenomics for stratified antidepressant treatment in major depressive disorder: evidence, limits and a roadmap for clinical use.Semantic proximity Read ↗

Therapy response prediction in major depressive disorder: current and novel genomic markers influencing pharmacokinetics and pharmacodynamics.Semantic proximity Read ↗

Genetics and personalized medicine in antidepressant treatment.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.